Is Viking Therapeutics (VKTX) Still Attractive After Its Recent Share Price Surge [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
If you are wondering whether Viking Therapeutics at around US$33.75 is still a sensible entry or hold after its run in the spotlight, you are not alone. The stock has moved 10.8% over the last 7 days, 4.7% over the past month, is down 4.7% year to date, and is up 19.2% over 1 year and 206.5% over 3 years, which naturally raises questions about how much of its story is already reflected in the price. These moves have kept Viking Therapeutics in focus for investors looking at biotech names with meaningful past share price swings and ongoing clinical and regulatory headlines in the sector. Recent coverage has often centred on how the company fits into a crowded field of drug developers and what that might mean for future funding, partnerships, or market attention. Right now Viking Therapeutics scores 3 out of 6 on our valuation checks, which suggests some areas look more attractive than others. We will walk through standard valuation methods next before finishing with a more compl
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Viking Therapeutics: Full-Speed Ahead [Seeking Alpha]Seeking Alpha
- Viking Therapeutics: Buyers Are Quietly Accumulating On Its Obesity Drugs Launch Potential [Seeking Alpha]Seeking Alpha
- Viking Therapeutics (VKTX) Valuation Check After Q4 2025 Earnings And Obesity Pipeline Progress [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- 1/26/26 - Form 4
- VKTX's page on the SEC website